Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
Psychopharmacology (Berl) ; 232(10): 1843-57, 2015 May.
Article de Anglais | MEDLINE | ID: mdl-25466701

RÉSUMÉ

RATIONALE: Ghrelin (Ghr) is a peptide that participates in the modulation of several biological processes. Ghr administration into the hippocampus improves learning and memory in different memory tests. However, the possible mechanisms underlying this effect on memory have not yet been clarified. OBJECTIVE: The purpose of the present work is to add new insights about the mechanisms by which Ghr modulates long-term memory consolidation in the hippocampus. We examined Ghr effects upon processes related to increased synaptic efficacy as presynaptic glutamate release and changes in the expression of the NR2B-subunits containing n-methyl-d-aspartate receptors (NMDAR), which are critical for LTP induction. We also attempted to determine the temporal window in which Ghr administration induces memory facilitation and if the described effects depend on GHS-R1a stimulation. RESULTS: The present research demonstrated that Ghr increased glutamate release from hippocampal synaptosomes; intra-hippocampal Ghr administration increased NR2B-subunits expression in CA1 and DG subareas and also reversed the deleterious effects of the NR2B-subunit-specific antagonist, Ro 25-6981, upon memory consolidation and LTP generation in the hippocampus. These effects are likely to be the consequence of GHS-R1a activation. CONCLUSION: According to the results above mentioned and previous findings, we can hypothesize some of the mechanisms by which Ghr modulates memory consolidation. At presynaptic level, Ghr stimulates glutamate release, probably by enhancing [Ca(2+)]i. At postsynaptic level, the glutamate released activates NMDAR while Ghr also mediates effects directly activating its specific receptors and increases NR2B-subunit expression.


Sujet(s)
Ghréline/pharmacologie , Acide glutamique/métabolisme , Hippocampe/métabolisme , Mémoire à long terme/physiologie , Récepteurs du N-méthyl-D-aspartate/biosynthèse , Animaux , Hippocampe/effets des médicaments et des substances chimiques , Mâle , Mémoire à long terme/effets des médicaments et des substances chimiques , Sous-unités de protéines/agonistes , Sous-unités de protéines/biosynthèse , Rats , Rat Wistar , Récepteurs du N-méthyl-D-aspartate/agonistes
2.
Neuroscience ; 197: 145-52, 2011 Dec 01.
Article de Anglais | MEDLINE | ID: mdl-21978882

RÉSUMÉ

A 13-amino acid peptide named neuronostatin (NST) encoded in the somatostatin pro-hormone has been recently reported. It is produced throughout the body, particularly in brain areas that have significant actions over the metabolic and autonomic regulation. The present study was performed in order to elucidate the functional role of NST on memory, anxiety-like behavior and food intake and the hippocampal participation in these effects. When the peptide was intra-hippocampally administered at 3.0 nmol/µl, it impaired memory retention in both, object recognition and step-down test. Also, this dose blocked the hippocampal long-term potentiation (LTP) generation. When NST was intra-hippocampally administered at 0.3 nmol/µl and 3.0 nmol/µl, anxiolytic effects were observed. Also, the administration in the third ventricle at the higher dose (3.0 nmol/µl) induced similar effects, and both doses reduced food intake. The main result of the present study is the relevance of the hippocampal formation in the behavioral effects induced by NST, and these effects could be associated to a reduced hippocampal synaptic plasticity.


Sujet(s)
Anxiété/métabolisme , Consommation alimentaire/physiologie , Hippocampe/métabolisme , Mémoire/physiologie , Fragments peptidiques/métabolisme , Somatostatine/métabolisme , Animaux , Consommation alimentaire/effets des médicaments et des substances chimiques , Hippocampe/effets des médicaments et des substances chimiques , Potentialisation à long terme/effets des médicaments et des substances chimiques , Potentialisation à long terme/physiologie , Mâle , Apprentissage du labyrinthe/effets des médicaments et des substances chimiques , Apprentissage du labyrinthe/physiologie , Mémoire/effets des médicaments et des substances chimiques , Techniques de patch-clamp , Rats , Rat Wistar
3.
Synapse ; 64(10): 742-53, 2010 Oct.
Article de Anglais | MEDLINE | ID: mdl-20698030

RÉSUMÉ

Hippocampus is a limbic structure that participates in learning and memory formation. Specifically the dentate gyrus has been described as a hippocampal subregion with high rates of plasticity and it is targeted by different psychoactive drugs modulating synaptic plasticity. Repeated cocaine administration induces sensitization to the locomotor effects and it is believed that sensitization involves the same mechanisms of drug seeking and relapse. Although, the mechanisms underlying sensitization is not fully understood. In this work we investigated the impact of repeated intraperitoneal administration of cocaine (15 or 20 mg/kg/day along 5 or 15 days respectively; and 15 mg/kg/day along 5 day followed by a challenge dose after three days of withdrawal) on the dentate gyrus synaptic plasticity, differentiating between sensitized and nonsensitized rats. Furthermore, we correlated changes on the hippocampal synaptic plasticity to memory retention. Our results revealed that the prevalence of cocaine sensitization (around 50%) was identical in all protocols used. The results found in the threshold to generate LTP were similar for all protocols used, being the threshold values cocaine-treated groups (sensitized and nonsensitized) significantly reduced compared to controls, observing the highest reduction in the sensitized group. Moreover, we observed a facilitated retention of recent memory formation only in sensitized animals the nonsensitized subjects remained at the control levels. In conclusion, sensitization to cocaine generates a high efficiency of hippocampal synaptic plasticity that may underlie the aberrant engagement of learning processes occurred during drug addiction.


Sujet(s)
Anesthésiques locaux/effets indésirables , Cocaïne/effets indésirables , Gyrus denté/effets des médicaments et des substances chimiques , Potentialisation à long terme/effets des médicaments et des substances chimiques , Activité motrice/effets des médicaments et des substances chimiques , Performance psychomotrice/effets des médicaments et des substances chimiques , Analyse de variance , Animaux , Comportement animal/effets des médicaments et des substances chimiques , Biophysique , Loi du khi-deux , Relation dose-effet des médicaments , Calendrier d'administration des médicaments , Stimulation électrique/méthodes , Potentiels post-synaptiques excitateurs/effets des médicaments et des substances chimiques , Potentiels post-synaptiques excitateurs/physiologie , Techniques in vitro , Potentialisation à long terme/physiologie , Mâle , Activité motrice/physiologie , Techniques de patch-clamp , Performance psychomotrice/physiologie , Rats , Rat Wistar , Statistiques comme sujet
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...